Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Rifampicin and Moxifloxacin in TB
NCT00306319Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2006
- Primary completion
- May 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of moxifloxacin in Tuberculosis (TB), sponsored by Radboud University Medical Center. Primary endpoint: Pharmacokinetic curves. Started Jan 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00306319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306319.